Curaleaf Holdings Inc (CURLF)
5.50
0.00 (0.00%)
USD |
OTCM |
May 10, 15:59
Curaleaf Holdings Enterprise Value: 4.667B for May 9, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 09, 2024 | 4.667B |
May 08, 2024 | 4.520B |
May 07, 2024 | 4.550B |
May 06, 2024 | 4.763B |
May 03, 2024 | 4.778B |
May 02, 2024 | 4.763B |
May 01, 2024 | 4.785B |
April 30, 2024 | 5.242B |
April 29, 2024 | 4.329B |
April 26, 2024 | 4.299B |
April 25, 2024 | 4.115B |
April 24, 2024 | 4.336B |
April 23, 2024 | 4.262B |
April 22, 2024 | 4.167B |
April 19, 2024 | 4.255B |
April 18, 2024 | 4.351B |
April 17, 2024 | 4.454B |
April 16, 2024 | 4.292B |
April 15, 2024 | 4.174B |
April 12, 2024 | 4.174B |
April 11, 2024 | 4.516B |
April 10, 2024 | 4.461B |
April 09, 2024 | 4.572B |
April 08, 2024 | 4.653B |
April 05, 2024 | 4.741B |
Date | Value |
---|---|
April 04, 2024 | 4.454B |
April 03, 2024 | 4.778B |
April 02, 2024 | 4.579B |
April 01, 2024 | 4.653B |
March 28, 2024 | 4.550B |
March 27, 2024 | 4.667B |
March 26, 2024 | 4.336B |
March 25, 2024 | 4.262B |
March 22, 2024 | 4.531B |
March 21, 2024 | 4.557B |
March 20, 2024 | 4.240B |
March 19, 2024 | 4.329B |
March 18, 2024 | 4.417B |
March 15, 2024 | 4.270B |
March 14, 2024 | 3.614B |
March 13, 2024 | 3.596B |
March 12, 2024 | 3.485B |
March 11, 2024 | 3.452B |
March 08, 2024 | 3.739B |
March 07, 2024 | 3.703B |
March 06, 2024 | 3.828B |
March 05, 2024 | 4.071B |
March 04, 2024 | 4.065B |
March 01, 2024 | 4.175B |
February 29, 2024 | 4.116B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.299B
Minimum
Mar 19 2020
12.51B
Maximum
Feb 10 2021
4.933B
Average
4.203B
Median
Enterprise Value Benchmarks
Flora Growth Corp | 12.75M |
Tilray Brands Inc | 1.752B |
Clever Leaves Holdings Inc | -1.279M |
Seelos Therapeutics Inc | 15.08M |
Zymeworks Inc | 307.56M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -63.23M |
Revenue (Quarterly) | 345.27M |
Total Expenses (Quarterly) | 331.30M |
EPS Diluted (Quarterly) | -0.08 |
Gross Profit Margin (Quarterly) | 45.24% |
Profit Margin (Quarterly) | -18.31% |
Earnings Yield | -6.91% |
Operating Earnings Yield | 0.97% |
Normalized Earnings Yield | -4.395 |